Dymista – CGC is responsible for communication on the gold standard in the treatment of allergic rhinitis.
With the fixed combination of azelastine and budesonide in an innovative galenic, Meda SE introduced a highly effective nasal spray for allergic rhinoconjunctivitis (AR) to the German market in 2015.
However, the market is characterized by a high OTC/self-medication share. Dymista is available only on prescription and must be prescribed by specialists (ENT, allergists) and general practitioners. CGC successfully handles the specialist and lay communication and Today, Dymista can be considered the gold standard in the treatment of AR.